237 related articles for article (PubMed ID: 23099318)
1. Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects.
Aboud AA; Tidball AM; Kumar KK; Neely MD; Ess KC; Erikson KM; Bowman AB
Neurotoxicology; 2012 Dec; 33(6):1443-1449. PubMed ID: 23099318
[TBL] [Abstract][Full Text] [Related]
2. PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper.
Aboud AA; Tidball AM; Kumar KK; Neely MD; Han B; Ess KC; Hong CC; Erikson KM; Hedera P; Bowman AB
Neurobiol Dis; 2015 Jan; 73():204-12. PubMed ID: 25315681
[TBL] [Abstract][Full Text] [Related]
3. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
[TBL] [Abstract][Full Text] [Related]
4. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
[TBL] [Abstract][Full Text] [Related]
5. Relationship between brain accumulation of manganese and aberration of hippocampal adult neurogenesis after oral exposure to manganese chloride in mice.
Kikuchihara Y; Abe H; Tanaka T; Kato M; Wang L; Ikarashi Y; Yoshida T; Shibutani M
Toxicology; 2015 May; 331():24-34. PubMed ID: 25698507
[TBL] [Abstract][Full Text] [Related]
6. The endoplasmic reticulum-mitochondria interface is perturbed in PARK2 knockout mice and patients with PARK2 mutations.
Gautier CA; Erpapazoglou Z; Mouton-Liger F; Muriel MP; Cormier F; Bigou S; Duffaure S; Girard M; Foret B; Iannielli A; Broccoli V; Dalle C; Bohl D; Michel PP; Corvol JC; Brice A; Corti O
Hum Mol Genet; 2016 Jul; 25(14):2972-2984. PubMed ID: 27206984
[TBL] [Abstract][Full Text] [Related]
7. Are there common biochemical and molecular mechanisms controlling manganism and parkisonism.
Roth JA
Neuromolecular Med; 2009; 11(4):281-96. PubMed ID: 19757210
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction and loss of Parkinson's disease-linked proteins contribute to neurotoxicity of manganese-containing welding fumes.
Sriram K; Lin GX; Jefferson AM; Roberts JR; Wirth O; Hayashi Y; Krajnak KM; Soukup JM; Ghio AJ; Reynolds SH; Castranova V; Munson AE; Antonini JM
FASEB J; 2010 Dec; 24(12):4989-5002. PubMed ID: 20798247
[TBL] [Abstract][Full Text] [Related]
9. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
10. ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese.
Rentschler G; Covolo L; Haddad AA; Lucchini RG; Zoni S; Broberg K
Neurotoxicology; 2012 Aug; 33(4):697-702. PubMed ID: 22285144
[TBL] [Abstract][Full Text] [Related]
11. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
12. Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies.
Hudnell HK
Neurotoxicology; 1999; 20(2-3):379-97. PubMed ID: 10385898
[TBL] [Abstract][Full Text] [Related]
13. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
[TBL] [Abstract][Full Text] [Related]
14. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
Zuo L; Motherwell MS
Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue.
Imaizumi Y; Okada Y; Akamatsu W; Koike M; Kuzumaki N; Hayakawa H; Nihira T; Kobayashi T; Ohyama M; Sato S; Takanashi M; Funayama M; Hirayama A; Soga T; Hishiki T; Suematsu M; Yagi T; Ito D; Kosakai A; Hayashi K; Shouji M; Nakanishi A; Suzuki N; Mizuno Y; Mizushima N; Amagai M; Uchiyama Y; Mochizuki H; Hattori N; Okano H
Mol Brain; 2012 Oct; 5():35. PubMed ID: 23039195
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of manganese-associated neurotoxicity.
Racette BA; Aschner M; Guilarte TR; Dydak U; Criswell SR; Zheng W
Neurotoxicology; 2012 Aug; 33(4):881-6. PubMed ID: 22202748
[TBL] [Abstract][Full Text] [Related]
17. Oxidative damage and neurodegeneration in manganese-induced neurotoxicity.
Milatovic D; Zaja-Milatovic S; Gupta RC; Yu Y; Aschner M
Toxicol Appl Pharmacol; 2009 Oct; 240(2):219-25. PubMed ID: 19607852
[TBL] [Abstract][Full Text] [Related]
18. Disease-Toxicant Interactions in Parkinson's Disease Neuropathology.
Kwakye GF; McMinimy RA; Aschner M
Neurochem Res; 2017 Jun; 42(6):1772-1786. PubMed ID: 27613618
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines.
Shaltouki A; Sivapatham R; Pei Y; Gerencser AA; Momčilović O; Rao MS; Zeng X
Stem Cell Reports; 2015 May; 4(5):847-59. PubMed ID: 25843045
[TBL] [Abstract][Full Text] [Related]
20. The divalent metal transporter homologues SMF-1/2 mediate dopamine neuron sensitivity in caenorhabditis elegans models of manganism and parkinson disease.
Settivari R; Levora J; Nass R
J Biol Chem; 2009 Dec; 284(51):35758-68. PubMed ID: 19801673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
